Trial intelligence / Profile preview

Effect of continuous tadalafil use on men’s sexual function after surgery

IRCT20201111049350N1Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tadalafil in erectile dysfunction (ED), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Sexual function improvement. Started Dec 2020; status: completed.

02

Drugs

tadalafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on IRCT20201111049350N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20201111049350N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call